Browse > Article
http://dx.doi.org/10.5090/kjtcs.2010.43.2.144

The Clinical Effects of Surgical Treatment for Hemoptysis due to Inflammatory Lung Disease  

Yun, Ju-Sik (Department of Thoracic and Cardiovascular Surgery, Mokpo National Hospital)
Na, Kook-Joo (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University Medical School)
CheKar, Jay-Key (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University Medical School)
Jeong, In-Seok (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University Medical School)
Song, Sang-Yun (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hwasun Hospital)
Oh, Sang-Gi (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University Medical School)
Publication Information
Journal of Chest Surgery / v.43, no.2, 2010 , pp. 144-149 More about this Journal
Abstract
Background: Many studies have demonstrated the various therapeutic options for treating hemoptysis caused by inflammatory lung disease. However, there is debate over the surgical management of the ongoing hemoptysis. Therefore, we evaluated the clinical results of pulmonary resection that was done due to hemoptysis in patients with concomitant inflammatory lung disease. Material and Method: We performed a retrospective analysis of 75 patients who received pulmonary resection for hemoptysis and concomitant inflammatory lung disease between 2001 and 2007. The mean age was $52.1{\pm}12.5$ years old, and the male; female ratio was 52:23. Result: The underlying disease was aspergilloma in 30 patients (40%), pulmonary tuberculosis in 20 patients, bronchiectasis in 18 patients and other causes in 7 patients. The surgical treatment included lobectomy in 55 patients, bilobectony in 2 patients, pneumonectomy in 17 patients and wedge resection in 1 patient. There were 3 early deaths, and the causes of death were pneumonia in 1 patient and BPF in 2 patients. The early mortality was statistically higher for such risk factors as a preoperative Hgb level <10 g/dL, COPD and an emergency operation. Conclusion: In conclusion, pulmonary resection for treating hemoptysis showed the acceptable range of mortality and it was an effective method for the management of hemoptysis in patients with inflammatory lung disease. However, relatively high rates of mortality and morbidity were noted for an emergency operation, and so meticulous care is needed in this situation.
Keywords
Lung surgery; Hemoptysis; Lung diseases;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Endo S, Otani S, Saito N, et al. Management of massive hemoptysis in a thoracic surgical unit. Eur J Cardiothorac Surg 2003;23:467-72   DOI   ScienceOn
2 Ayed A. Pulmonary resection for massive hemoptysis of benign etiology. Eur J Cardiothorac Surg 2003;24:689-93   DOI   ScienceOn
3 Remy J, Arnaud A, Fardou H, Giraud R, Voisin C. Treatment of hemoptysis by embolisation of bronchial arteries. Radiology 1977;122:33-7   DOI   PUBMED
4 Mal H, Rullon I, Mellot F, et al. Immediate and long-term results of bronchial artery embolisation for life threatening hemoptysis. Chest 1999;115:996-1001   DOI   ScienceOn
5 White RI. Bronchial artery embolotherapy for control of acute hemoptysis. Chest 1999;115:912-5   DOI   PUBMED   ScienceOn
6 Conlan AA, Hurwitz SS, Krige L, Nicolaou N, Pool R. Massive hemoptysis. J Thorac Cardiovasc Surg 1983;85:120-4   PUBMED
7 Endo S, Otani S, Saito N, et al. Management of massive hemoptysis in a thoracic surgical unit. Eur J Cardiothorac Surg 2003;23:467-72   DOI   ScienceOn
8 Jougon J, Ballester M, Delcambre F, et al. Massive hemoptysis: what place for medical and surgical treatment. Eur J Cardiothorac Surg 2002;22:345-51   DOI   ScienceOn
9 Garzon AA, Gourin A. Surgical management of massive hemoptysis. Ann Surg 1978;187:267-71   DOI   ScienceOn
10 Thompson AB, Teschler H, Rennard SI. Pathogenesis, evaluation, and therapy for massive hemoptysis. Clin Chest Med 1992;13:69-82   PUBMED
11 Hirshberg B, Biran I, Glaser M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest 1997;112:440-4   DOI   PUBMED   ScienceOn
12 Seo YH, Kim NY, Kuh JH, Kim MH. Clinical results of pulmonary resection for hemoptysis of inflammatory lung disease. Korean J Thorac Cardiovasc Surg 1994;27:36-42
13 Erdogan A, Yegin A, Gürses G, Demircan A. Surgical management of tuberculosis-related hemoptysis. Ann Thorac Surg 2005;79:299-302   DOI   ScienceOn
14 McCollun WB, Mattox KL, Guinn GA, Beall AC Jr. Immediate operative treatment for massive hemoptysis. Chest 1975;67:152-5   DOI   ScienceOn
15 Lee HR, Chung HK. Surgical evaluation of hemoptysis patients. Korean J Thorac Cardiovasc Surg 1987;20:128-38